May. 7 at 2:24 PM
$TRDA Nathan J. Dowden, President and COO of Entrada Therapeutics, Inc. (NASDAQ:TRDA), sold 15,000 common shares of the company on May 4, 2026. The transactions totaled
$229,953, with shares sold at a weighted average price of
$15.3302, in a range between
$15.00 and
$15.69 per share.
The sale is followed by the exercise of stock options for an equivalent of 15,000 ordinary shares on the same day. These shares were acquired at an exercise price of
$1.74 per share, for a total of
$26,100. The options were fully matured on November 4, 2023
